USE OF ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELLS FOR THE TREATMENT OF GRAFT VERSUS HOST DISEASE

摘要

The present invention relates to the use of a particular type of adipose tissue derived mesenchymal stem cells (AD-MSCs), which exert immunosuppressive properties, in the manufacture of a pharmaceutical composition for the prevention and treatment of the graft-versus-host disease (GVHD) produced after allogeneic hematopoietic stem cell transplantation.